• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    NAMSA Acquires American Preclinical Services

    Quidel's QuickVue At-Home COVID-19 Test Earns EUA

    Memic Receives FDA Marketing Authorization for Hominis

    Varian CEO to Retire Following Siemens Healthineers Acquisition

    Olympus to Purchase Israeli Firm Medi-Tate to Grow Urology Biz
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Rethink Your Medtech ASC Strategy, Part 1

    Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

    Tips for Reigniting Your MDR/IVDR Preparation

    Three Major Innovation Opportunities for Biomedical Textiles

    Use Vertical Integration to Increase Productivity, Drive Innovation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Medicoil

    MW Life Sciences

    Unicep

    FUTEK Advanced Sensor Technology Inc.

    Forefront Medical Technology
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Grant Funding Works and How It Can Help

    Refurbished Medical Equipment Testing and Certification Under the NEC

    Taking the First Step with Metal Components

    4 Trends Driving Medical Manufacturing in 2021

    Pioneering AI Solutions to Reinforce Healthcare Services
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Medbio LLC

    Forefront Medical Technology

    Concise Engineering

    PTI Engineered Plastics Inc.

    maxon
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Preparing for MDR: Test In-House or Outsource?

    As the EU MDR deadline draws near, manufacturers are under pressure to bring products into compliance and get submissions in front of regulators ASAP.

    Preparing for MDR: Test In-House or Outsource?
    Related CONTENT
    • Diversity, Inclusion, and Innovation at The MedTech Conference
    • U.S. May Offer a Safe Harbor from the Impending MDR Storm
    • Globalization: Will Your 2019 Regulatory Strategy Help You Win in 2020?
    • First Come, First Served: Class I Manufacturers Stand in Line for EU MDR Certification
    • Trends, Opportunities, and Drivers in Early-Stage Life Sciences Investing
    Sandi Schaible, Senior Director, Analytical Chemistry and Regulatory Toxicology, WuXi Medical Device Testing10.08.19
    As the EU medical device regulation (MDR) deadline draws near, medical device manufacturers are increasingly under pressure to bring products into compliance and get submissions in front of regulators as soon as possible. With the MDR journey well underway, device manufacturers should have their gap analyses complete and roadmaps to the finish line thoroughly planned out. However, the industry is behind.

    Where OEMs Are Now vs. Where They Should Be
    Many manufacturers are running behind with their MDR implementation. Depending on how many products they need to test and who is carrying out testing, the process can take months or even years. Many small and mid-size companies are not ready due to limited resources, lack of regulatory knowledge, or simply not knowing where to start. Companies with a larger volume of products may be more at risk, especially if they haven’t begun prioritizing products. However, those with fewer products and less ground to make up should already be working toward MDR compliance. If they’re not, it’s time to put the pedal to the metal.

    Deciding on a Path Forward
    OEMs have two options to complete pre-clinical device testing. The first is to conduct their own testing using in-house facilities and personnel. Companies that do not already have facilities up and running would have a lot to accomplish before testing can even begin; at this point, building an in-house lab may not be feasible. The alternative option is to outsource testing to a specialized lab or contract research organization (CRO). There are pros and cons to each approach, and selecting the best path forward comes down to several factors unique to the device manufacturer. Following are some criteria to help determine the best path forward.

    The Pros of In-House Testing
    There are a few advantages to having an in-house testing facility:
    • Ownership: Owning the medical device testing process grants a company control over the whole project, from technical insights and cost through timing and submission decisions, etc. Most importantly, medtech firms can reprioritize products in real-time, if challenges arise. Due to the high demand for testing services in the face of MDR, laboratory testing facilities continue to experience capacity constraints. Handling projects internally allows organizations to avoid competing with other companies for priority or dealing with the headache of securing a spot in line.
    • Direct lines of communication: Internal communications may be easier and more efficient because it eliminates outside involvement and could shorten response time.
    If an organization elects to take testing in-house, it’s essential to consider the steps needed to run a viable testing facility. As long as the internal team is aware of the latest testing standards, regulatory expectations, has experience with extractables and leachables (E/L) studies, and has written risk assessments on medical device products in the past, they should be in good shape. But be aware the cost savings associated with in-house testing may be offset by the expense of building an internal facility and purchasing standard lab equipment (the latter alone could cost millions of dollars).

    Pros of Outsourcing Testing
    The greatest downfall of in-house testing ahead of MDR is the unforgiving timeline. In-house testing requires physical space, technology, personnel, expertise, equipment, and more to execute successfully. If a company doesn’t already have these, now may not be the time to take a DIY approach. Due to labs’ specialization, analytical methods, and regulatory knowledge, going the outsourcing route may be the better option for MDR testing. Here are a few reasons why:
    • Reputation: Working with a lab may help boost submission credibility in regulators’ eyes. Regulators want to ensure companies have not introduced any biased views in technical files and chemistry reports. Involving an unbiased third party is one way to accomplish this.
    • Access to insider knowledge: In-house testing facilities in their infancy won’t have access to extensive chemical databases, as these libraries are built slowly over time. CROs, on the other hand, have visibility to all types of products, regulations, new standards, and questions or requests that may come from regulatory agencies. This visibility allows experienced lab testing partners to adapt quickly and draw upon broad exposure and experiences when dealing with the unexpected. Learnings gleaned from identifications can be leveraged to inform decisions and trends. This process can be harder for in-house labs.
    • Recruitment: Staffing an in-house facility with qualified experts can be a complicated, drawn-out process. It is important to hire seasoned chemistry and toxicology experts versus generalists, as experience in the field of medical device testing will make a big difference. Similar to how there are many types of doctors, there are specialized toxicologists and chemists. Some scientists may appear qualified at first glance, but may not have previous experience with E/L testing medical devices, identifying unknown chemicals, or addressing the immune response or toxicity of a specific chemical. Risk assessments require specific tools and methods, and staff must know how to use proper analytical methods. Think of it this way: It wouldn’t be wise to have a primary physician attempt open-heart surgery. Specialization in the field of medical device testing works the same way.
    • Timeliness: MDR is a big task, but outsourcing some work to a qualified lab can help reduce the burden of staffing and training, allowing for more focus on other critical tasks. Further, a lab is a good option to ensure testing is done sequentially and all biological endpoints are met. Establishing strong partnerships increases efficiency and eliminates the potential for miscommunication between parties or gaps in information.
    Even if outsourcing all testing isn’t the desired route, building a relationship with a lab can help in emergencies, such as equipment failing, staff turnover, or projects outside staffs’ expertise.

    General Advice for MDR Planning
    Aside from which approach an organization takes to testing, knowing general guidelines is helpful throughout the approval process. First, don’t underestimate the strictness of deadlines. At this point, it is unlikely Europe will grant an extension on MDR, and even if that happens, it may not occur until the very last minute. Don’t count on an extension. Second, carefully prioritize product lines. Focus on products that have the highest market demand and return on investment. Finally, approach partnerships with transparency—be forthcoming with details, and give lab partners visibility to forecasts, intervals, and timelines. Providing as much detail up front as possible, setting aside privacy concerns, and sharing honest feedback helps ensure long-term success.

    The day MDR officially goes into effect, May 26, 2020, will be here before we know it. There’s no time left to procrastinate, so companies should keep their foot on the gas and take charge of their approach to MDR. 


    Sandi Schaible is senior director of Analytical Chemistry and Regulatory Toxicology at WuXi Medical Device Testing, a global pharmaceutical and medical device open-access capability and technology platform company. She specializes in extractables and leachables studies. Sandi is a U.S. delegate and international delegate for ISO 10993 part 18 in chemical characterization. She is also a U.S. delegate for ISO 10993 part 13 and the particulates committee (TIR42).
    Related Searches
    • research
    • metal
    • iso
    • standard
    Related Knowledge Center
    • Testing
    Suggested For You
    Diversity, Inclusion, and Innovation at The MedTech Conference Diversity, Inclusion, and Innovation at The MedTech Conference
    U.S. May Offer a Safe Harbor from the Impending MDR Storm U.S. May Offer a Safe Harbor from the Impending MDR Storm
    Globalization: Will Your 2019 Regulatory Strategy Help You Win in 2020? Globalization: Will Your 2019 Regulatory Strategy Help You Win in 2020?
    First Come, First Served:  Class I Manufacturers Stand in Line for EU MDR Certification First Come, First Served: Class I Manufacturers Stand in Line for EU MDR Certification
    Trends, Opportunities, and Drivers in Early-Stage Life Sciences Investing Trends, Opportunities, and Drivers in Early-Stage Life Sciences Investing
    Boston Centerless Appoints Impact Ireland (Metals) Ltd. as Exclusive U.K. & Ireland Distributor Boston Centerless Appoints Impact Ireland (Metals) Ltd. as Exclusive U.K. & Ireland Distributor
    Connecting the Dots in Medical Device Outsourcing Connecting the Dots in Medical Device Outsourcing
    Mayday: How the Upcoming MDR Implementation Forecasts Disaster for Our Industry Mayday: How the Upcoming MDR Implementation Forecasts Disaster for Our Industry
    The OEM’s Roadmap to Navigating MDR The OEM’s Roadmap to Navigating MDR
    Turning a Regulatory Headache into a Competitive Advantage Turning a Regulatory Headache into a Competitive Advantage
    Automation: The First Step to Industry 4.0 Automation: The First Step to Industry 4.0
    Toughened Epoxy Polysulfide Hybrid Offers Advanced Chemical Resistance Toughened Epoxy Polysulfide Hybrid Offers Advanced Chemical Resistance
    The Future of Medtech Manufacturing The Future of Medtech Manufacturing
    Revisiting the End: A Packaging and Sterilization Update Revisiting the End: A Packaging and Sterilization Update
    Package Testing and Validation: Interplay Between ISO 11607 Updates and MDR Package Testing and Validation: Interplay Between ISO 11607 Updates and MDR

    Related Columns

    • Testing
      Going Beyond the Regulations to Evaluate Relevant Medical Device Risk

      Going Beyond the Regulations to Evaluate Relevant Medical Device Risk

      Companies need to review their testing plan so it supports a successful submission, saves time, and ensures the long-term success of their product.
      Sherry Parker, Ph.D., Senior Director of Regulatory Toxicology, WuXi AppTec Medical Device Testing 06.04.20

    • Testing
      The Importance of Usability/Human Factors Testing

      The Importance of Usability/Human Factors Testing

      When is the work of human factors over, and how does your team know they are prepared for summative testing?
      Maria Shepherd, President and Founder, Medi-Vantage 03.04.20

    • Materials | Testing
      Particle Particulars: Why this Analysis Is Foundational for Successful Devices

      Particle Particulars: Why this Analysis Is Foundational for Successful Devices

      In the mid-2000s, medical device experts were hopeful they’d found one solution to longer-lasting implants.
      Dawn A. Lissy, President & Founder, Empirical 03.04.20


    • R&D & Design | Testing
      FDA Guidelines for Employing X-ray Inspection in Medical Device Development

      FDA Guidelines for Employing X-ray Inspection in Medical Device Development

      Different materials exhibit different radiopacity as a function of material composition (i.e. atomic weight) and thickness.
      Gil Zweig, President, Glenbrook Technologies 01.29.20

    • Testing
      Managing Risks for Medical Devices:  A Guide to Understanding ISO 14971

      Managing Risks for Medical Devices: A Guide to Understanding ISO 14971

      The intent of ISO 14971 is to provide a general “bird’s-eye view” approach to designing and implementing a risk management plan for medical devices.
      Helin Räägel, Ph.D., Biocompatibility Expert, Nelson Labs 10.08.19

    • Testing
      Why Big Companies With Internal Labs Should Outsource Testing

      Why Big Companies With Internal Labs Should Outsource Testing

      ...
      Dawn A. Lissy, President & Founder, Empirical 03.07.19


    • Packaging & Sterilization | Testing
      Coming Clean: Developing Standards for Cleaning Reusable Devices and Instruments

      Coming Clean: Developing Standards for Cleaning Reusable Devices and Instruments

      ...
      Dawn A. Lissy, President & Founder, Empirical 07.26.18

    • 3D/Additive Manufacturing | Testing
      The Final Four: My Top Headlines for 2017

      The Final Four: My Top Headlines for 2017

      ...
      Dawn A. Lissy, President & Founder, Empirical 11.07.17

    • Packaging & Sterilization | Testing
      Packaging Validations—Looking Beyond ISO 11607

      Packaging Validations—Looking Beyond ISO 11607

      ...
      Christopher Scott, Vice President, Eurofins Medical Device Testing 10.05.17


    • Testing
      So We’re All on the Same Page: You Need a Test Plan

      So We’re All on the Same Page: You Need a Test Plan

      ...
      Dawn A. Lissy, Empirical 09.01.17

    • 3D/Additive Manufacturing | R&D & Design | Testing
      Pro Tips for Prototypes: The Smart Way to Manage Device Iterations

      Pro Tips for Prototypes: The Smart Way to Manage Device Iterations

      ...
      Dawn A. Lissy, Empirical 07.26.17

    • Digital Health | Software & IT | Testing
      Recent Cyber Attack Enough to Make Medtech WannaCry

      Recent Cyber Attack Enough to Make Medtech WannaCry

      ...
      Michael Barbella, Managing Editor 06.06.17


    • R&D & Design | Testing
      The Human Factor

      The Human Factor

      ...
      Steve Maylish and Dave Hines, Fusion Biotec 05.01.17

    • Testing
      Peruvian Prospects:  The Medical Device Industry of a Country Founded on Precious Metals

      Peruvian Prospects: The Medical Device Industry of a Country Founded on Precious Metals

      ...
      Dawn A. Lissy, President & Founder, Empirical 04.03.17

    • Testing
      Extractable/Leachable Chemistry Testing Strategies for Medical Devices

      Extractable/Leachable Chemistry Testing Strategies for Medical Devices

      ...
      Matthew R Jorgensen, Ph.D., and Thor Rollins, BS, Nelson Laboratories; Allison Komiyama, Ph.D., RAC, AcKnowledge RS 04.03.17


    Trending
    • FDA Breakthrough Device Designation Awarded To BrainCool AB's Cooral System
    • Mike On Medtech: Update On FDA's STeP Designation
    • Hardy Diagnostics Releases Rapid Test For COVID-19
    • Quidel's QuickVue At-Home COVID-19 Test Earns EUA
    • NAMSA Acquires American Preclinical Services
    Breaking News
    • Dexcom Launches Inaugural Venture Capital Fund
    • FDA Clears HydroMID Midline Catheter From Access Vascular
    • NAMSA Acquires American Preclinical Services
    • Quidel's QuickVue At-Home COVID-19 Test Earns EUA
    • Memic Receives FDA Marketing Authorization for Hominis
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • Seeking a Revolution in Clinical Care Through AI
    • Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit
    • Addition by Subtraction: The Latest of Machining for Medtech
    • Innovation Incubators: An R&D Roundtable
    • Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Low Levels of Vitamin D and Calcium Linked to COVID-19 Severity
    Probiotic Evidenced to Assist Digestive Recovery from a Complex Surgery
    AHPA Submits Comments to FDA on Proposed Traceability Rule
    Coatings World

    Latest Breaking News From Coatings World

    Chromaflo Technologies Adds Benjamin Woeste as Territory Sales Manager
    AOC Announces EMEA Price Increase
    Mule-Hide Products Co. Introduces Seal-Fast Liqui-Flash
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Dexcom Launches Inaugural Venture Capital Fund
    FDA Clears HydroMID Midline Catheter From Access Vascular
    NAMSA Acquires American Preclinical Services
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Fusion Pharmaceuticals Acquires IPN-1087
    Strata Oncology Unveils Strata PATH Trial
    Alimentiv Acquires McDougall Scientific
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Coty Partners with LanzaTech to Introduce Sustainable Ethanol
    IT Cosmetics Supports Women’s Confidence
    Inter Parfums Reports a Strong Fourth Quarter
    Happi

    Latest Breaking News From Happi

    Coty Partners with LanzaTech to Reduce Its Environmental Impact
    Waterless Beauty, Simplified Routines Shape Clean Beauty at Whole Foods
    Redken Updates Packaging, Adds New Products
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Flint Group Packaging announces global price increase
    Abbott Label installs Domino K600i dual bar digital UV inkjet printer
    Crossmark turns to Eagle Systems for cold foil
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Principle Business Enterprises Celebrates 60 Years
    Mann+Hummel Invests in Pamlico Air
    Domtar Completes Sale of Personal Care Business
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Coronavirus Triggers Double-Digit Revenue Dropoff at Smith+Nephew
    FDA Approves Accufix Surgical's Accu-Joint Hemi Implant
    FDA OKs Q-Collar Device to Protect Athletes’ Brains During Head Impacts
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login